Ads
    Related paper
  1. Structure-Based Identification of Some Potential Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) With In-silico Assessment of Their Pharmacokinetic Features and Quantum Chemical Calculations
  2. Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
  3. Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor (VEGF) expression in Sinonasal Inverted Papillomas
  4. Oxadiazole derivatives as potential egfr protein kinase inhibitors: prediction of in-silico admet properties and molecular docking study
  5. QSAR APPROACH TO THE STUDY OF THE EGFR TYROSINE KINASE INHIBITORS: THIAZOLYL-PYRAZOLINE DERIVATIVES
  6. In silico screening of 3,4 dihydropyrimidones as focal adhesion tyrosine kinase inhibitors
  7. In Silico Identification of Some Novel Ketoamides as Potential Pan-Genotypic HCV NS3/4A Protease Inhibitors with Drug-Likeness, Pharmacokinetic ADME Profiles and Synthetic Accessibility Predictions
  8. Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
  9. In-Silico ADMET Prediction, Structure-Based Drug Design and Molecular Docking Studies of Quinazoline Derivatives as Novel EGFR Inhibitors
  10. Study of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor Expression by Immunohistochemistry in Breast Carcinoma